• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Commercial Officer Hartnett Jennifer Catherine sold $1,107,623 worth of shares (9,506 units at $116.52), decreasing direct ownership by 15% to 53,903 units (SEC Form 4)

    6/9/25 6:02:31 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $ELF alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Hartnett Jennifer Catherine

    (Last) (First) (Middle)
    C/O E.L.F. BEAUTY, INC.
    570 10TH STREET

    (Street)
    OAKLAND CA 94607

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    e.l.f. Beauty, Inc. [ ELF ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Commercial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    06/05/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, $0.01 par value 06/05/2025 S(1) 500 D $114.466(2) 62,909(3) D
    Common Stock, $0.01 par value 06/05/2025 S(1) 3,570 D $115.6954(4) 59,339(3) D
    Common Stock, $0.01 par value 06/05/2025 S(1) 2,040 D $116.325(5) 57,299(3) D
    Common Stock, $0.01 par value 06/05/2025 S(1) 1,200 D $117.7403(6) 56,099(3) D
    Common Stock, $0.01 par value 06/05/2025 S(1) 700 D $118.3158(7) 55,399(3) D
    Common Stock, $0.01 par value 06/05/2025 S(8) 1,496 D $117.61 53,903(3) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 4, 2024.
    2. The transaction was executed in multiple trades in prices ranging from $113.95 to $114.91, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    3. Includes 52,024 Restricted Stock Units ("RSUs").
    4. The transaction was executed in multiple trades in prices ranging from $114.98 to $115.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    5. The transaction was executed in multiple trades in prices ranging from $116.08 to $117.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    6. The transaction was executed in multiple trades in prices ranging from $117.12 to $118.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    7. The transaction was executed in multiple trades in prices ranging from $118.17 to $118.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    8. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to RSUs of the Issuer.
    /s/ Scott K. Milsten, Attorney-in-Fact for Jennifer Catherine Hartnett 06/09/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ELF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ELF

    DatePrice TargetRatingAnalyst
    2/7/2025$158.00 → $74.00Buy → Neutral
    UBS
    2/7/2025$153.00 → $70.00Overweight → Equal-Weight
    Morgan Stanley
    2/7/2025$170.00 → $80.00Buy → Neutral
    DA Davidson
    1/13/2025$139.00 → $153.00Equal-Weight → Overweight
    Morgan Stanley
    12/13/2024$165.00Buy
    Goldman
    12/12/2024$133.00Hold
    Deutsche Bank
    10/16/2024$210.00 → $130.00Buy
    Truist
    9/10/2024$175.00Buy
    B. Riley Securities
    More analyst ratings